News
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the ...
Globus Medical GMED +0.38% Get Free Report has outperformed the market over the past 10 years by 1.4% on an annualized basis ...
RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Globus Medical (GMED – Research Report) on April 15 and set a price target ...
It is hard to get excited after looking at Globus Medical's (NYSE:GMED) recent performance, when its stock has ...
In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...
Detailed price information for Globus Medical Inc (GMED-N) from The Globe and Mail including charting and trades.
BTIG lowered the firm’s price target on Globus Medical (GMED) to $88 from $94 and keeps a Buy rating on the shares as part of a broader ...
Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. However, a challenging macroeconomic scenario continues to plague Globus Medical. The stock ...
Globus Medical (NYSE:GMED) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results